Makovski V et al. |
Farnesylthiosalicylic acid (salirasib) inhibits Rheb in TSC2-null ELT3 cells: a potential treatment for lymphangioleiomyomatosis. |
2012 |
Int. J. Cancer |
pmid:21500191
|
Piérard GE et al. |
Miconazole, a pharmacological barrier to skin fungal infections. |
2012 |
Expert Opin Pharmacother |
pmid:22568580
|
Tashiro M et al. |
Pravastatin inhibits farnesol production in Candida albicans and improves survival in a mouse model of systemic candidiasis. |
2012 |
Med. Mycol. |
pmid:21954955
|
Jaggi AS and Singh N |
Analgesic potential of intrathecal farnesyl thiosalicylic acid and GW 5074 in vincristine-induced neuropathic pain in rats. |
2012 |
Food Chem. Toxicol. |
pmid:22326968
|
Qamar W et al. |
Benzo(a)pyrene-induced pulmonary inflammation, edema, surfactant dysfunction, and injuries in rats: alleviation by farnesol. |
2012 |
Exp. Lung Res. |
pmid:22168545
|
Mashiach-Farkash E et al. |
Computer-based identification of a novel LIMK1/2 inhibitor that synergizes with salirasib to destabilize the actin cytoskeleton. |
2012 |
Oncotarget |
pmid:22776759
|
Mor A et al. |
Celecoxib enhances the anti-inflammatory effects of farnesylthiosalicylic acid on T cells independent of prostaglandin E(2) production. |
2012 |
Inflammation |
pmid:22688643
|
Nasr N et al. |
HIV-1 infection of human macrophages directly induces viperin which inhibits viral production. |
2012 |
Blood |
pmid:22677126
|
Cordeiro Rde A et al. |
Farnesol inhibits in vitro growth of the Cryptococcus neoformans species complex with no significant changes in virulence-related exoenzymes. |
2012 |
Vet. Microbiol. |
pmid:22580194
|
Costa CB et al. |
Farnesyltransferase inhibitors: molecular evidence of therapeutic efficacy in acute lymphoblastic leukemia through cyclin D1 inhibition. |
2012 |
Anticancer Res. |
pmid:22399601
|
Han TL et al. |
The metabolic response of Candida albicans to farnesol under hyphae-inducing conditions. |
2012 |
FEMS Yeast Res. |
pmid:22846172
|
Chang W et al. |
Retigeric acid B attenuates the virulence of Candida albicans via inhibiting adenylyl cyclase activity targeted by enhanced farnesol production. |
2012 |
PLoS ONE |
pmid:22848547
|
Lindsay AK et al. |
Farnesol and cyclic AMP signaling effects on the hypha-to-yeast transition in Candida albicans. |
2012 |
Eukaryotic Cell |
pmid:22886999
|
Fu MS et al. |
Functional characterization of the small heat shock protein Hsp12p from Candida albicans. |
2012 |
PLoS ONE |
pmid:22880130
|
Lichtor PA and Miller SJ |
Combinatorial evolution of site- and enantioselective catalysts for polyene epoxidation. |
2012 |
Nat Chem |
pmid:23174978
|
Shin KO et al. |
Terpene alcohols inhibit de novo sphingolipid biosynthesis. |
2012 |
Planta Med. |
pmid:22274813
|
Jin Y and Qiu FG |
A convergent stereocontrolled total synthesis of (-)-terpestacin. |
2012 |
Org. Biomol. Chem. |
pmid:22710980
|
Mologni L et al. |
Synergistic effects of combined Wnt/KRAS inhibition in colorectal cancer cells. |
2012 |
PLoS ONE |
pmid:23227266
|
Wartenberg D et al. |
Proteome analysis of the farnesol-induced stress response in Aspergillus nidulans--The role of a putative dehydrin. |
2012 |
J Proteomics |
pmid:22634043
|
Falsetta ML et al. |
Novel antibiofilm chemotherapy targets exopolysaccharide synthesis and stress tolerance in Streptococcus mutans to modulate virulence expression in vivo. |
2012 |
Antimicrob. Agents Chemother. |
pmid:22985885
|